title: Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes.
authors.forename: J
authors.initials: J
authors.lastname: Loeffler-Ragg
authors.forename: M
authors.initials: M
authors.lastname: Steurer
authors.forename: H
authors.initials: H
authors.lastname: Ulmer
authors.forename: S
authors.initials: S
authors.lastname: Skvortsov
authors.forename: B
authors.initials: B
authors.lastname: Kircher
authors.forename: M
authors.initials: M
authors.lastname: Herold
authors.forename: H
authors.initials: H
authors.lastname: Zwierzina
authors.forename: R
authors.initials: R
authors.lastname: Stauder
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015820:Cadherins / Q000097:blood*; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000401:mortality*; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D015415:Biomarkers; D015820:Cadherins; D018960:Hyaluronan Receptors